Common questions about Lutinus (FAQ)
Q: What is Lutinus prescribed for, generally?
A: Official documents clearly state that Lutinus is indicated exclusively for luteal support as part of an Assisted Reproductive Technology (ART) treatment program for infertile women. It is not approved or intended for other general uses.
Q: Is Lutinus used for conditions other than fertility treatment?
A: According to the official therapeutic indications listed by regulatory bodies, Lutinus is indicated exclusively for luteal support in women undergoing an Assisted Reproductive Technology (ART) program. It has no other formally approved indications.
Q: What is the role of progesterone when a person is not pregnant?
A: The fundamental role of progesterone, the active ingredient in Lutinus, is to provide targeted hormonal support within the reproductive system. Its primary function is to promote endometrial transformation, which is the process of preparing the inner lining of the womb for a potential pregnancy, a key process during the luteal phase of the cycle.
Q: Why is Lutinus sometimes prescribed after ovulation induction?
A: Lutinus is formally indicated for luteal support as part of an Assisted Reproductive Technology (ART) treatment program. Ovulation induction is often the initial stage of the ART process, which is then followed by the need for progesterone support (luteal support) after egg retrieval.
Q: How quickly should Lutinus start working after I begin using it?
A: Studies on the drug's activity show that maximum levels of progesterone in the blood typically occur between 8 and 12 hours after the first dose. According to the official product information, consistent, steady-state levels of the hormone are generally reached within about one day after starting treatment.
Q: Is it normal to experience light bleeding or spotting while using Lutinus?
A: Yes, some light bleeding or spotting is a possibility. Clinical trial data indicates that vaginal bleeding is a documented adverse reaction, although it is considered common, affecting between 1 and 10 in every 100 patients. Undiagnosed bleeding, however, is listed as a contraindication for using the medicine.
Q: Is it normal to have breast tenderness while using Lutinus?
A: Official documents for progesterone products note that breast tenderness and other breast discomforts may be an expected adverse reaction associated with the use of progesterone.
Q: Can Lutinus cause gastrointestinal issues like nausea or stomach cramps?
A: Yes, regulatory documents list several gastrointestinal issues as common side effects of Lutinus, meaning they occur in 1 to 10 out of every 100 patients. These commonly reported effects include nausea, abdominal pain, abdominal distension (bloating), and uterine cramps.
Q: Can using Lutinus cause changes in mood or make me feel irritable?
A: Yes, changes in mood are a recognized effect. Official product information lists irritability and mood swings as expected adverse reactions associated with progesterone use. Additionally, patients with a history of depression are advised to be closely monitored during treatment.
Q: How is the feeling of dizziness or drowsiness associated with Lutinus described in official documents?
A: Official product information notes that the medicine has a minor to moderate influence on the ability to drive or operate machinery. This is because Lutinus may cause drowsiness and/or dizziness (Dizziness is listed as an uncommon side effect).
Q: Can Lutinus cause weight changes or fluid retention?
A: Official warnings note that progesterone may cause some degree of fluid retention in the body, which is also described in the safety profile as peripheral oedema (swelling). For patients with conditions that are susceptible to being worsened by fluid retention, such as certain cardiac or kidney issues, careful observation is required.
Q: Does Lutinus affect cholesterol or blood sugar levels?
A: While Lutinus is primarily a progesterone product, official precautions note that similar hormone therapies have shown decreased glucose tolerance and changes in insulin sensitivity. Consequently, careful observation throughout the course of treatment is required for patients with diabetes. The official documents do not directly state an effect on cholesterol.
Q: Can people with a history of depression use Lutinus?
A: Official regulatory warnings state that patients with a history of depression need to be closely observed during treatment. If symptoms of depression worsen, discontinuation of the medicine may be considered by a healthcare professional.
Q: Is it possible to be allergic to an ingredient in Lutinus?
A: Official regulatory documents state that use of Lutinus is strictly contraindicated (must be avoided) in any individual with a known hypersensitivity (allergic reaction) to the active substance, progesterone, or to any of the non-active ingredients listed in the tablet’s composition.
Q: Are there any common interactions with antibiotics or antifungal medications?
A: The antibiotic Rifampicin and the antifungal Ketoconazole are specifically noted in interaction warnings as they can affect progesterone levels in the body. Furthermore, official documentation advises against using other vaginal products—which may include certain antifungal creams—at the same time as Lutinus, as this could interfere with absorption.
Q: Does Lutinus interact with vitamin supplements or herbal products?
A: Regulatory documents state that certain herbal products may influence how the body handles the medicine. Specifically, products containing St. John’s Wort (Hypericum perforatum) are known to potentially decrease the medicine's overall effectiveness. Discussing all supplements and herbal products with a healthcare professional is advised.
Q: Can Lutinus affect the results of other medical lab tests?
A: Official safety warnings indicate that a decrease in glucose tolerance (the body's ability to process sugar) has been observed in some patients using similar hormone-based therapies. For this reason, careful observation throughout the course of treatment is required for patients with diabetes. Progesterone may also affect results of tests that rely on hormone levels.
Q: Does Lutinus contain any ingredients derived from animals or plants?
A: The active ingredient, progesterone, is a bio-identical steroid hormone. Regulatory composition documents list the presence of an excipient known as lactose monohydrate, which is a substance derived from milk.
Q: What does the FDA or other regulatory bodies say about the efficacy of Lutinus?
A: Efficacy was established through a core clinical trial that focused on key outcomes like the Ongoing Pregnancy Rate and Live Birth Rate. These studies reported that the medication's performance fell within the predefined non-inferiority range when compared to a reference progesterone treatment.
Q: How is the research evidence for Lutinus described in medical literature?
A: The main evidence used for regulatory approval includes Randomized Controlled Trials (RCTs). These studies primarily focused on establishing non-inferiority compared to other progesterone treatments, with primary endpoints including the Live Birth Rate in women undergoing fresh embryo transfer protocols.
